BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 19901077)

  • 1. Aurora-A phosphorylates, activates, and relocalizes the small GTPase RalA.
    Lim KH; Brady DC; Kashatus DF; Ancrile BB; Der CJ; Cox AD; Counter CM
    Mol Cell Biol; 2010 Jan; 30(2):508-23. PubMed ID: 19901077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RALA and RALBP1 regulate mitochondrial fission at mitosis.
    Kashatus DF; Lim KH; Brady DC; Pershing NL; Cox AD; Counter CM
    Nat Cell Biol; 2011 Aug; 13(9):1108-15. PubMed ID: 21822277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ral GTPases in tumorigenesis: emerging from the shadows.
    Kashatus DF
    Exp Cell Res; 2013 Sep; 319(15):2337-42. PubMed ID: 23830877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sec5 and Exo84 foster oncogenic ras-mediated tumorigenesis.
    Issaq SH; Lim KH; Counter CM
    Mol Cancer Res; 2010 Feb; 8(2):223-31. PubMed ID: 20145037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RalBP1 is necessary for metastasis of human cancer cell lines.
    Wu Z; Owens C; Chandra N; Popovic K; Conaway M; Theodorescu D
    Neoplasia; 2010 Dec; 12(12):1003-12. PubMed ID: 21170262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coupling mitochondrial and cell division.
    Yamano K; Youle RJ
    Nat Cell Biol; 2011 Sep; 13(9):1026-7. PubMed ID: 21892144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of RalA is critical for Ras-induced tumorigenesis of human cells.
    Lim KH; Baines AT; Fiordalisi JJ; Shipitsin M; Feig LA; Cox AD; Der CJ; Counter CM
    Cancer Cell; 2005 Jun; 7(6):533-45. PubMed ID: 15950903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual effects of Ral-activated pathways on p27 localization and TGF-β signaling.
    Tazat K; Harsat M; Goldshmid-Shagal A; Ehrlich M; Henis YI
    Mol Biol Cell; 2013 Jun; 24(11):1812-24. PubMed ID: 23576547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RalA, a GTPase targeted by miR-181a, promotes transformation and progression by activating the Ras-related signaling pathway in chronic myelogenous leukemia.
    Gu C; Feng M; Yin Z; Luo X; Yang J; Li Y; Li T; Wang R; Fei J
    Oncotarget; 2016 Apr; 7(15):20561-73. PubMed ID: 26967392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and characterization of small molecules that target the GTPase Ral.
    Yan C; Liu D; Li L; Wempe MF; Guin S; Khanna M; Meier J; Hoffman B; Owens C; Wysoczynski CL; Nitz MD; Knabe WE; Ahmed M; Brautigan DL; Paschal BM; Schwartz MA; Jones DN; Ross D; Meroueh SO; Theodorescu D
    Nature; 2014 Nov; 515(7527):443-7. PubMed ID: 25219851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to MLN8237 in pancreatic cancer is not dependent on RalA phosphorylation.
    Neel NF; Stratford JK; Shinde V; Ecsedy JA; Martin TD; Der CJ; Yeh JJ
    Mol Cancer Ther; 2014 Jan; 13(1):122-33. PubMed ID: 24222664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The RalB small GTPase mediates formation of invadopodia through a GTPase-activating protein-independent function of the RalBP1/RLIP76 effector.
    Neel NF; Rossman KL; Martin TD; Hayes TK; Yeh JJ; Der CJ
    Mol Cell Biol; 2012 Apr; 32(8):1374-86. PubMed ID: 22331470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ras-related small GTPases RalA and RalB regulate cellular survival after ionizing radiation.
    Kidd AR; Snider JL; Martin TD; Graboski SF; Der CJ; Cox AD
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):205-12. PubMed ID: 20619549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RalA activation at nascent lamellipodia of epidermal growth factor-stimulated Cos7 cells and migrating Madin-Darby canine kidney cells.
    Takaya A; Ohba Y; Kurokawa K; Matsuda M
    Mol Biol Cell; 2004 Jun; 15(6):2549-57. PubMed ID: 15034142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of V23RalA-Ser194 as a critical mediator for Aurora-A-induced cellular motility and transformation by small pool expression screening.
    Wu JC; Chen TY; Yu CT; Tsai SJ; Hsu JM; Tang MJ; Chou CK; Lin WJ; Yuan CJ; Huang CY
    J Biol Chem; 2005 Mar; 280(10):9013-22. PubMed ID: 15637052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RalA signaling pathway as a therapeutic target in hepatocellular carcinoma (HCC).
    Ezzeldin M; Borrego-Diaz E; Taha M; Esfandyari T; Wise AL; Peng W; Rouyanian A; Asvadi Kermani A; Soleimani M; Patrad E; Lialyte K; Wang K; Williamson S; Abdulkarim B; Olyaee M; Farassati F
    Mol Oncol; 2014 Jul; 8(5):1043-53. PubMed ID: 24785097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of cargo exocytosis by a Reps1-Ralbp1-RalA module.
    Wang S; Chen X; Crisman L; Dou X; Winborn CS; Wan C; Puscher H; Yin Q; Kennedy MJ; Shen J
    Sci Adv; 2023 Feb; 9(8):eade2540. PubMed ID: 36812304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of RalA signaling pathway in treatment of non-small cell lung cancer.
    Male H; Patel V; Jacob MA; Borrego-Diaz E; Wang K; Young DA; Wise AL; Huang C; Van Veldhuizen P; O'Brien-Ladner A; Williamson SK; Taylor SA; Tawfik O; Esfandyari T; Farassati F
    Lung Cancer; 2012 Aug; 77(2):252-9. PubMed ID: 22498113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RalA is overactivated in medulloblastoma.
    Ginn KF; Fangman B; Terai K; Wise A; Ziazadeh D; Shah K; Gartrell R; Ricke B; Kimura K; Mathur S; Borrego-Diaz E; Farassati F
    J Neurooncol; 2016 Oct; 130(1):99-110. PubMed ID: 27566179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating the role of Aurora kinases in RAS signaling.
    Kosik A; Bekier ME; Katusin JD; Kaur H; Zhou X; Diakonova M; Chadee DN; Taylor WR
    J Cell Biochem; 2009 Jan; 106(1):33-41. PubMed ID: 19009561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.